Open your mind.
Sunday, September 27, 2009
Saturday, September 12, 2009
[link] MAPS Newsletters
http://www.maps.org/news-letters/
The MAPS Bulletin is typically published tri-annually, and all MAPS members receive a complimentary subscription. MAPS also distributes the Bulletin as an educational tool to scientists, government officials, drug war prisoners, and influential academics.
The MAPS Bulletin first appeared as a one page MAPS Newsletter in 1988. In 1995, after growing successively longer with each issue, the "Newsletter" became the MAPS Bulletin. Many issues feature psychedelically-inspired artwork on the covers.
Interested parties wishing to copy any portion of these articles are encouraged to do so and are kindly requested to credit MAPS, including name and address. The Bulletin is produced by a small group of dedicated staff and volunteers focused primarily on assisting scientists to conduct human studies to generate essential information about the risks and psychotherapeutic benefits of MDMA, other psychedelics, and marijuana, with the goal of eventually gaining government approval for their medical uses.
Interested in distributing the Bulletin? Contact Randolph Hencken, MAPS' Director of Communications and Marketing, at randolph@maps.org
To order a back issue of the Bulletin email orders@maps.org
The MAPS Bulletin is typically published tri-annually, and all MAPS members receive a complimentary subscription. MAPS also distributes the Bulletin as an educational tool to scientists, government officials, drug war prisoners, and influential academics.
The MAPS Bulletin first appeared as a one page MAPS Newsletter in 1988. In 1995, after growing successively longer with each issue, the "Newsletter" became the MAPS Bulletin. Many issues feature psychedelically-inspired artwork on the covers.
Interested parties wishing to copy any portion of these articles are encouraged to do so and are kindly requested to credit MAPS, including name and address. The Bulletin is produced by a small group of dedicated staff and volunteers focused primarily on assisting scientists to conduct human studies to generate essential information about the risks and psychotherapeutic benefits of MDMA, other psychedelics, and marijuana, with the goal of eventually gaining government approval for their medical uses.
Interested in distributing the Bulletin? Contact Randolph Hencken, MAPS' Director of Communications and Marketing, at randolph@maps.org
To order a back issue of the Bulletin email orders@maps.org
Subscribe to:
Posts (Atom)